Bharat Biotech signs deal with Washington University School of Medicine in St Louis for COVID-19…
Bharat Biotech owns the rights to distribute the chimp-adenovirus, single-dose intranasal vaccine candidate in all markets except…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Krishna Ella
COVAXIN from Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials
The human trials of this vaccine candidate for COVID-19, indigenously developed in collaboration with ICMR-NIV, will start across…
CSIR sanctions project to develop human monoclonal antibodies as therapy for COVID-19 infections
The project, led by Bharat Biotech, brings together academia - National Centre for Cell Science (NCCS), Pune and Indian Institute…
Ella Foundation completes preliminary studies on Ebola vaccine
The programme is an important step from Ella Foundation to support World Immunisation Goals